March 2012
Volume 53, Issue 14
ARVO Annual Meeting Abstract  |   March 2012
Implication of GPx4 in Choroidal Neovascularization
Author Affiliations & Notes
  • Murilo F. Roggia
    Ophthalmology, University of Tokyo, Tokyo, Japan
  • Takashi Ueta
    Ophthalmology, University of Tokyo, Tokyo, Japan
  • Imai Hirotaka
    Pharmaceutical Sciences, Kitasato University, Tokyo, Japan
  • Tatsuya Inoue
    Ophthalmology, University of Tokyo, Tokyo, Japan
  • Yasuhiro Tamaki
    Ophthalmology, University of Tokyo, Tokyo, Japan
  • Yasuo Yanagi
    Ophthalmology, University of Tokyo, Tokyo, Japan
  • Footnotes
    Commercial Relationships  Murilo F. Roggia, None; Takashi Ueta, None; Imai Hirotaka, None; Tatsuya Inoue, None; Yasuhiro Tamaki, None; Yasuo Yanagi, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 5828. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Murilo F. Roggia, Takashi Ueta, Imai Hirotaka, Tatsuya Inoue, Yasuhiro Tamaki, Yasuo Yanagi; Implication of GPx4 in Choroidal Neovascularization. Invest. Ophthalmol. Vis. Sci. 2012;53(14):5828.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Oxidative stress has been implicated in the pathogenesis of age-related macular degeneration (AMD). Here we evaluate the implication of glutathione peroxidase 4 (GPx4), an antioxidant enzyme that is involved in the reduction of cell membrane-associated peroxidized phospholipid, in the choroidal neovascularization (CNV) model and basal VEGF-A expression level in the retinal pigment epithelium (RPE)/choroid.

Methods: : We used three groups of mice expressing different levels of GPx4; i.e. GPx4+/mice, GPx4+/+ mice and mice transgenically overexpressing GPx4 (GPx4+/+:Tg(GPx4)+/). VEGF-A mRNA and protein level in the RPE/choroid was compared among the three groups before and 7 days after the CNV induction by laser treatment. Laser-induced CNV followed the standard protocol and analysis of the CNV size was performed using FITC- dextran staining of the flatmount 7 days after laser.

Results: : First we established the mechanism of VEGF-A expression before and after CNV induction. Although VEGF-A protein level was upregulated by the CNV induction, there was no difference in the VEGF-A mRNA before and after laser treatment, indicating the importance of the post-transcriptional regulation of VEGF-A in pathological CNV. Before laser treatment, GPx4 positively regulated both VEGF-A mRNA expression and protein level in the RPE/choroid. However, after laser treatment, GPx4 negatively regulated VEGF-A protein level, although VEGF-A mRNA was still positively regulated by GPx4. Consistent with the VEGF-A protein level, CNV size was two-time larger in the GPx4+/mice than that in the mice overexpressing GPx4.

Conclusions: : Physiologically, GPx4 increased VEGF-A expression by controlling its mRNA expression. However, in the pathological CNV, GPx4 had a protective role against CNV by a post-transcriptional modulation of VEGF-A expression.

Keywords: choroid: neovascularization • age-related macular degeneration • antioxidants 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.